Study title: Ploetz J. et al:Inhibitory Effect of Dantrolene on the Rise of Serum-Ck Activity After Combined Use of Halothane and Succinylcholine in Man; Anaesthesist 30 (7), 338-342 (1981)Ploetz J. et al:Inhibitory Effect of Dantrolene on the Rise of Serum-Ck Activity After Combined Use of Halothane and Succinylcholine in Man; Anaesthesist 30 (7), 338-342 (1981)
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Musculoskeletal Diseases [C05] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: DANTROLENE | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |